Unusual late development of dopamine agonist resistance in two women with hyperprolactinaemia associated with transition from micro to macroadenoma.
McCall
D
D
Hunter
S J
SJ
Cooke
R S
RS
Herron
B
B
Sheridan
B
B
Atkinson
A B
AB
D000328:Adult; D000077465:Cabergoline; D018450:Disease Progression; D018491:Dopamine Agonists / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm; D004873:Ergolines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000188:drug therapy* / Q000209:etiology; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D015175:Prolactinoma / Q000150:complications / Q000188:drug therapy* / Q000473:pathology
D018491:Dopamine Agonists; D004873:Ergolines; D000077465:Cabergoline